Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Lee

Showing results (81-90 of 150) with videos related to

Pageof 15
Sort By:
Scientific Reports|August 24, 2017
Aluminum plasmonic nanoshielding in ultraviolet inactivation of bacteriaJeremy N Kunz, Dmitri V Voronine, Weigang Lu, et al.
Diabetes, Obesity & Metabolism|November 2, 2021
A double-blind, placebo-controlled, single-ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136, a novel long-acting glucagon analogue, in healthy subjectsKi Young Huh, Jun Gi Hwang, Wonjung Shin, et al.
Clinical and Translational Science|November 17, 2020
YH12852, a Potent and Selective Receptor Agonist of 5-hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional ConstipationHyun A Lee, Seol Ju Moon, Hyounggyoon Yoo, et al.
Clinical and Translational Science|August 19, 2025
First-In-Human Study of Safety, Tolerability, Efficacy, and Pharmacokinetics of CPNE7-Derived Peptide (Selcopintide) for Dentin HypersensitivityMyung Jin Lee, Yoon Seon Lee, Joo-Cheol Park, et al.
Antibody Therapeutics|April 3, 2024
Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISAAnhye Kim, Min-Seok Oh, Gwan-Ho Lee, et al.
Drug Design, Development and Therapy|August 26, 2014
Predictive performance of gentamicin dosing nomogramsJieon Lee, Seonghae Yoon, Donghoon Shin, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2020
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage RegimenLien Ngo, Jaeseong Oh, Anhye Kim, et al.
International Journal of Molecular Sciences|April 9, 2020
A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMET<sup>TM</sup> Plus PlatformJeong-An Gim, Yonghan Kwon, Hyun A Lee, et al.
Drug Design, Development and Therapy|January 29, 2014
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteersSeonghae Yoon, Howard Lee, Tae-Eun Kim, et al.
Science Advances|May 21, 2025
Control of ultrafast hot electron dynamics in epsilon-near-zero conductive oxide thin filmsSudip Gurung, Subhajit Bej, Quynh Dang, et al.
Pageof 15

Showing results (81-90 of 150) with videos related to

Sort By:
Pageof 15
Scientific Reports|August 24, 2017
Aluminum plasmonic nanoshielding in ultraviolet inactivation of bacteriaJeremy N Kunz, Dmitri V Voronine, Weigang Lu, et al.
Diabetes, Obesity & Metabolism|November 2, 2021
A double-blind, placebo-controlled, single-ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of HM15136, a novel long-acting glucagon analogue, in healthy subjectsKi Young Huh, Jun Gi Hwang, Wonjung Shin, et al.
Clinical and Translational Science|November 17, 2020
YH12852, a Potent and Selective Receptor Agonist of 5-hydroxytryptamine, Increased Gastrointestinal Motility in Healthy Volunteers and Patients With Functional ConstipationHyun A Lee, Seol Ju Moon, Hyounggyoon Yoo, et al.
Clinical and Translational Science|August 19, 2025
First-In-Human Study of Safety, Tolerability, Efficacy, and Pharmacokinetics of CPNE7-Derived Peptide (Selcopintide) for Dentin HypersensitivityMyung Jin Lee, Yoon Seon Lee, Joo-Cheol Park, et al.
Antibody Therapeutics|April 3, 2024
Understanding the pharmacokinetic journey of Fc-fusion protein, rhIL-7-hyFc using complementary approach of two analytical methods, accelerator mass spectrometry and ELISAAnhye Kim, Min-Seok Oh, Gwan-Ho Lee, et al.
Drug Design, Development and Therapy|August 26, 2014
Predictive performance of gentamicin dosing nomogramsJieon Lee, Seonghae Yoon, Donghoon Shin, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 18, 2020
Development of a Pharmacokinetic Model Describing Neonatal Fc Receptor-Mediated Recycling of HL2351, a Novel Hybrid Fc-Fused Interleukin-1 Receptor Antagonist, to Optimize Dosage RegimenLien Ngo, Jaeseong Oh, Anhye Kim, et al.
International Journal of Molecular Sciences|April 9, 2020
A Machine Learning-Based Identification of Genes Affecting the Pharmacokinetics of Tacrolimus Using the DMET<sup>TM</sup> Plus PlatformJeong-An Gim, Yonghan Kwon, Hyun A Lee, et al.
Drug Design, Development and Therapy|January 29, 2014
Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteersSeonghae Yoon, Howard Lee, Tae-Eun Kim, et al.
Science Advances|May 21, 2025
Control of ultrafast hot electron dynamics in epsilon-near-zero conductive oxide thin filmsSudip Gurung, Subhajit Bej, Quynh Dang, et al.
Pageof 15